Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2010
12/23/2010WO2010147830A2 Aminothiazole modulators of beta-3-adrenoreceptor
12/23/2010WO2010147430A2 Novel c-aryl glucoside sglt2 inhibitors and pharmaceutical composition comprising same
12/23/2010WO2010147234A1 Diarylamide-spirodiamine derivative
12/23/2010WO2010147226A1 Pyrazinooxazepine derivatives
12/23/2010WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor
12/23/2010WO2010146597A1 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors
12/23/2010WO2010146395A1 Pyrazine carboxamides as inhibitors of dgat1
12/23/2010WO2010146299A1 Azetidine-derived esters, preparation thereof, and therapeutic use thereof as cannabinoid receptor modulators
12/23/2010WO2010146104A1 Thiadiazole derivatives and their use for the treatment of disorders mediated by slpl receptors
12/23/2010WO2010146078A2 Novel uses of hydroxyproline compositions
12/23/2010WO2010145903A1 New therapeutical uses of inecalcitol
12/23/2010WO2010145376A1 Tripeptide boronic acid or boronic ester, preparative method and use thereof
12/23/2010WO2010145192A1 Mangiferin-berberine salt, manufacturing method and use thereof
12/23/2010WO2010128528A3 Piperidine derivatives useful for treatment of diebetes
12/23/2010WO2010127264A3 HNF4α ANTAGONISTS AND METHODS OF USE
12/23/2010WO2010119161A3 Antiepileptic, hypocholesterolemic and neuroprotective compound
12/23/2010WO2010115830A3 Pharmaceutical agent
12/23/2010WO2010067339A3 Fusion protein capable of binding vegf-a and tnf-alpha
12/23/2010US20100324140 Glucagon receptor antagonists, preparation and therapeutic uses
12/23/2010US20100324122 Modulation of sglt2 expression
12/23/2010US20100324106 Compounds
12/23/2010US20100324105 Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
12/23/2010US20100324104 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
12/23/2010US20100324095 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324084 Urea derivatives of tropane, their preparation and their therapeutic application
12/23/2010US20100324082 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS
12/23/2010US20100324076 Novel sEH Inhibitors and their Use
12/23/2010US20100324075 Therapeutic use of carboxyl ester lipase inhibitors
12/23/2010US20100324073 Pyrazolo [1,5-A] Pyrimidine Compounds
12/23/2010US20100324071 Novel glucokinase activators and methods of using same
12/23/2010US20100324068 Chemical compounds 785
12/23/2010US20100324054 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/23/2010US20100324049 Diaryl ketimine derivative having antagonism against melanin-concentrating hormone receptor
12/23/2010US20100324039 Substituted Indolealkanoic Acids
12/23/2010US20100324033 Oxadiazoanthracene compounds for the treatment of diabetes
12/23/2010US20100324026 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/23/2010US20100324009 Substituted Sulfonamide Compounds
12/23/2010US20100324005 Method for treatment of diseases
12/23/2010US20100324004 Method for Treating Diabetes
12/23/2010US20100324001 Novel Methods for the Treatment of Inflammatory Diseases
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
12/23/2010US20100323991 Methods and products for treatment of diseases
12/23/2010US20100323988 Solid citrate and tartrate salts of dpp-iv inhibitors
12/23/2010US20100323981 Treatment of statin side effects
12/23/2010US20100323956 Glucose-regulating polypeptides and methods of making and using same
12/23/2010US20100323955 Methods for treating obesity and obesity related diseases and disorders
12/23/2010US20100323954 Chimeric polypeptides and uses thereof
12/23/2010US20100323045 Extract formulation of opuntia ficus indica
12/23/2010US20100323039 Labisia pumila extracts for reducing the risk of cardiovascular diseases
12/23/2010US20100323031 Synergistic combination to enhance blood glucose and insulin metabolism
12/23/2010US20100323027 Mesenchymal stem cell conditioned medium
12/23/2010US20100323026 Sustained release preparation for tissue regeneration therapy
12/23/2010US20100323019 Microparticles for the treatment of disease
12/23/2010US20100323011 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
12/23/2010US20100323008 Solid dosage form comprising a fibrate
12/23/2010US20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same
12/23/2010US20100322930 Fibronectin-based binding molecules and their use
12/23/2010US20100322915 Protease Variants for Pharmaceutical Use
12/23/2010US20100322913 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
12/23/2010US20100322906 Method for Obtaining Pancreatic Endocrine Cells From Adipose Tissue-Origin Cells
12/23/2010US20100322894 Combination Therapies for Treating Type 1 Diabetes
12/23/2010US20100322863 Methods and Uses of Anti-IL-23 Antibodies
12/23/2010US20100322856 Compositions and Methods for Inducing Angiogenesis
12/23/2010US20100322853 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010DE102009025119A1 Herstellung und Verwendung antitumoraler, antibiotischer und insektizider Cyclodepsipeptide Production and use of antitumor, antimicrobial and insecticidal cyclodepsipeptides
12/23/2010CA2765026A1 Gip receptor-active glucagon compounds
12/23/2010CA2764013A1 Pyrazine carboxamides as inhibitors of dgat1
12/23/2010CA2762458A1 New therapeutical uses of inecalcitol
12/22/2010EP2264179A1 Aminosugar compound and process for production thereof
12/22/2010EP2264172A1 Oligomeric compounds for the modulation of HIF-1alpha expression
12/22/2010EP2264064A1 Modified exendins and exendin agonists
12/22/2010EP2264059A1 Polypeptides, cDNAs encoding the same and utilization thereof
12/22/2010EP2264034A1 Bicyclic pyrrole compound
12/22/2010EP2264029A1 1,3-dihydroisobenzofuran derivative
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2264026A1 Alkylaminopyridine derivative
12/22/2010EP2264017A1 Heterocyclic derivative and use thereof
12/22/2010EP2264015A1 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263677A1 New therapeutical uses of inecalcitol
12/22/2010EP2263670A1 Use of angiotensin II receptor antagonists in order to increase insulin sensitivity
12/22/2010EP2263663A1 Compositions comprising curcuminoids and either alpha or beta acids for use in the treatment of diabetes
12/22/2010EP2263655A1 Pharmaceutical formulation comprising atorvastatin calcium
12/22/2010EP2263480A1 Composition for promotion of bone growth and maintenance of bone health, comprising Mentha extracts
12/22/2010EP2262821A2 Process for the extraction of mangiferin and isomangiferin
12/22/2010EP2262785A1 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
12/22/2010EP2262778A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxcr1 and p40
12/22/2010EP2262777A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cri
12/22/2010EP2262770A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
12/22/2010EP2262763A2 Compounds and methods of treating obesity
12/22/2010EP2262525A1 Apoaequorin-containing compositions and methods of using same
12/22/2010EP2262514A1 Agents for promoting secretion and/or suppressing decrease of adiponectin
12/22/2010EP2262500A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
12/22/2010EP2262498A2 Pyrimidines and pyridines useful as inhibitors of protein kinases
12/22/2010EP2262496A1 Compounds and compositions as modulators of gpr119 activity
12/22/2010EP2041100B1 Substituted 5- phenylamino- 1, 3, 4-oxadiaz0l-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase
12/22/2010EP2029534B1 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
12/22/2010EP1805156B1 Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
12/22/2010EP1676862B1 Recombinant antibody against human insulin-like growth factor
1 ... 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 ... 1298